ストックスクリーナーアプリを入手
1.66
0.00%
0.00
アフターアワーズ：
1.69
0.03
+1.81%
前日終値:
$1.66
開ける：
$1.66
24時間の取引高:
675.81K
Relative Volume:
0.34
時価総額：
$84.23M
収益：
-
当期純損益:
$-67.68M
株価収益率:
-1.00
EPS:
-1.66
ネットキャッシュフロー:
$-54.24M
1週間 パフォーマンス:
-0.60%
1か月 パフォーマンス:
-6.21%
6か月 パフォーマンス:
-33.60%
1年 パフォーマンス:
-75.41%
1日の値動き範囲:
$1.625
$1.71
1週間の範囲:
$1.58
$1.73
52週間の値動き範囲:
$0.9857
$7.27
Cabaletta Bio Inc Stock (CABA) Company Profile
CABA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
1.66 | 149.31M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-20 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-12-19 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | 開始されました | UBS | Buy |
| 2024-02-05 | 開始されました | Jefferies | Buy |
| 2023-11-29 | 開始されました | William Blair | Outperform |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-19 | 開始されました | Stifel | Buy |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-07-18 | 開始されました | Guggenheim | Buy |
| 2023-01-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | 開始されました | Wells Fargo | Overweight |
| 2021-10-19 | 再開されました | Morgan Stanley | Overweight |
| 2021-06-30 | 開始されました | Mizuho | Buy |
| 2021-01-08 | 開始されました | Chardan Capital Markets | Buy |
| 2020-10-13 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-19 | 開始されました | Cowen | Outperform |
| 2019-11-19 | 開始されました | Evercore ISI | Outperform |
| 2019-11-19 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Cabaletta Bio Inc (CABA) 最新ニュース
When is Cabaletta Bio Inc. stock expected to show significant growthAccess high-quality stock research instantly - jammulinksnews.com
Should I hold or sell Cabaletta Bio Inc. stock in 2025Capitalize on emerging trends for profits - jammulinksnews.com
What is Cabaletta Bio Inc. company’s growth strategyAchieve unparalleled market performance - jammulinksnews.com
How does Cabaletta Bio Inc. generate profit in a changing economyOutperformance with explosive growth - jammulinksnews.com
What catalysts could drive Cabaletta Bio Inc. stock higher in 2025Superior return velocity - jammulinksnews.com
How strong is Cabaletta Bio Inc. company’s balance sheetMaximize gains with data-driven trading alerts - jammulinksnews.com
Cabaletta Bio Inc. Company Revenue and Profit Trends: A Deep Dive200 Percent Watchlist - Metal.it
Cabaletta Bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SayShort Term High Return Strategy - Newser
What makes Cabaletta Bio Inc. stock price move sharplyBuild wealth faster with expert stock picks - jammulinksnews.com
Will Cabaletta Bio Inc. Stock Benefit from AI and Green Energy TrendsLong Term Secure Gain Stocks - Newser
Is Cabaletta Bio Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Stock Selection - Newser
How Resilient Is Occidental Petroleum Corporation Stock During Economic Downturns3x Return Stock Radar - Newser
Why Cabaletta Bio Inc. stock attracts strong analyst attentionSwing Trade Signals - Metal.it
What drives Cabaletta Bio Inc. stock priceRapid market gains - PrintWeekIndia
Why Cabaletta Bio Inc. stock is on top investor watchlistsSkyrocketing returns - jammulinksnews.com
What analysts say about Cabaletta Bio Inc. stockHigh-yield capital appreciation - Autocar Professional
Cabaletta Bio Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com
Is Cabaletta Bio Inc. a good long term investmentUnprecedented profits - jammulinksnews.com
Will Cabaletta Bio Inc. stock benefit from interest rate changesPredictable High Return Trades - Newser
Cabaletta Bio’s RESET-SLE Study: A Promising Step in Lupus Treatment - TipRanks
Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment - The Globe and Mail
What institutions are buying Cabaletta Bio Inc. stock nowFree Predictions - Newser
Cabaletta Bio’s RESET-Myositis Study: A Promising Step in Autoimmune Treatment - TipRanks
Cabaletta Bio’s RESET-MG Study: A Promising Step in Myasthenia Gravis Treatment - TipRanks
How Cabaletta Bio Inc. stock performs during market volatilityFree Wealth-Building Investment Strategies - beatles.ru
Cabaletta Bio Inc (CABA) 財務データ
収益
当期純利益
現金流量
EPS
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):